Expertise in
10
conditions

Dr. James P. Wymer

Neurology
Uf Health Neuromedicine-Fixel Institute
3009 SW Williston Rd, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
Uf Health Neuromedicine-Fixel Institute
3009 SW Williston Rd, 
Gainesville, FL 

Overview

James Wymer is a Neurologist practicing medicine in Gainesville, Florida.

Dr. Wymer is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, and Gastrostomy.

He is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 9 clinical trials. Dr. Wymer is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in NY

Hospital Affiliations

Uf Health Shands Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Uf Health Neuromedicine-Fixel Institute
3009 SW Williston Rd, Gainesville, FL 32608
Other Locations
UF Health Comprehensive Spine Center
1505 SW Archer Rd, Gainesville, FL 32608

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Not Applicable
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
Enrollment Status: Active_not_recruiting
Publish Date: August 20, 2026
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Unknown
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 4
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
Enrollment Status: Withdrawn
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials

64 Total Publications

Diagnostic differences between military veterans and non-veterans: data from the United States National ALS Registry.
Diagnostic differences between military veterans and non-veterans: data from the United States National ALS Registry.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: May 29, 2026
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral required
Before you request

Uf Health Neuromedicine-Fixel Institute

3009 SW Williston Rd, 
Gainesville, FL 
 (0.1 miles away)
352-294-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Okun is a Neurologist practicing medicine in Gainesville, Florida. Dr. Okun is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Deep Brain Stimulation, and Thalamotomy. Dr. Okun is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Uf Health Neuromedicine-Fixel Institute

3009 SW Williston Rd, 
Gainesville, FL 
 (0.1 miles away)
352-294-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nikolaus Mcfarland is a Neurologist practicing medicine in Gainesville, Florida. Dr. Mcfarland is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Movement Disorders, and Parkinson's Disease. Dr. Mcfarland is currently accepting new patients.

Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

Uf Health Neuromedicine-Fixel Institute

3009 SW Williston Rd, 
Gainesville, FL 
 (0.1 miles away)
352-294-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Irene Malaty is a Neurologist practicing medicine in Gainesville, Florida. Dr. Malaty is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Movement Disorders, Parkinson's Disease, Tourette Syndrome, and Deep Brain Stimulation. Dr. Malaty is currently accepting new patients.

Frequently Asked Questions about Dr. James P. Wymer

How do I make an appointment with Dr. James P. Wymer?

You can book an appointment with Dr. James P. Wymer by calling their office at 352-294-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James P. Wymer a top-rated expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James P. Wymer is classified as an Elite expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James P. Wymer specialize in?

While Dr. James P. Wymer is a Neurology, they have specific expertise in Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Spinal Muscular Atrophy Type 3. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. James P. Wymer participate in research or clinical trials?

Yes. Dr. James P. Wymer has published 64 articles and abstracts on conditions like Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). You can view a list of Dr. James P. Wymer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James P. Wymer accept my insurance?

Dr. James P. Wymer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 352-294-5400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wymer's expertise for a condition
ConditionClose
View All 40 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile